EUS-guided fine needle biopsy of pancreatic masses can yield true histology
Ji Young Bang, Shantel Hebert-Magee, Udayakumar Navaneethan, Muhammad K Hasan, Robert Hawes, Shyam Varadarajulu, Ji Young Bang, Shantel Hebert-Magee, Udayakumar Navaneethan, Muhammad K Hasan, Robert Hawes, Shyam Varadarajulu
No abstract availableKeywords: endoscopic ultrasonography; pancreatic cancer.
Conflict of interest statement
Competing interests: SV: consultant for olympusm medical systems corporation and Boston scientific corporation. RH: consultant for olympus medical systems corporation and boston scientific corporation.
Figures
References
- Chantrill LA, Nagrial AM, Watson C, et al. . Precision medicine for advanced pancreas cancer: the individualized molecular pancreatic cancer therapy (IMPaCT) trial. Clin Cancer Res 2015;21:2029–37. 10.1158/1078-0432.CCR-15-0426
- Varadarajulu S, Tamhane A, Eloubeidi MA. Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis. Gastrointest Endosc 2005;62:728–36. 10.1016/j.gie.2005.06.051
- Hébert-Magee S, Bae S, Varadarajulu S, et al. . The presence of a cytopathologist increases the diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration cytology for pancreatic adenocarcinoma: a meta-analysis. Cytopathology 2013;24:159–71. 10.1111/cyt.12071
- Hingorani SR, Harris WP, Beck JT, et al. . Phase Ib Study of PEGylated Recombinant human hyaluronidase and gemcitabine in patients with advanced pancreatic cancer. Clin Cancer Res 2016;22:2848–54. 10.1158/1078-0432.CCR-15-2010
- Bang JY, Hebert-Magee S, Hasan MK, et al. . Endoscopic ultrasonography-guided biopsy using a Franseen needle design: initial assessment. Dig Endosc 2017;29:338–46. 10.1111/den.12769
- Kandel P, Tranesh G, Nassar A, et al. . EUS-guided fine needle biopsy sampling using a novel fork-tip needle: a case-control study. Gastrointest Endosc 2016;84:1034–9. 10.1016/j.gie.2016.03.1405
- Han P, Che D, Pallav K, et al. . Models of the cutting edge geometry of medical needles with applications to needle design. Int J Mech Sci 2012;65:157–67. 10.1016/j.ijmecsci.2012.09.014
- Sato N, Cheng XB, Kohi S, et al. . Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma. Acta Pharm Sin B 2016;6:101–5. 10.1016/j.apsb.2016.01.002
- Jacobetz MA, Chan DS, Neesse A, et al. . Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. Gut 2013;62:112–20. 10.1136/gutjnl-2012-302529
- Bournet B, Muscari F, Buscail C, et al. . KRAS G12D mutation subtype is a prognostic factor for advanced pancreatic adenocarcinoma. Clin Transl Gastroenterol 2016;7:e157 10.1038/ctg.2016.18
- Kopelman Y, Marmor S, Ashkenazi I, et al. . Value of EUS-FNA cytological preparations compared with cell block sections in the diagnosis of pancreatic solid tumours. Cytopathology 2011;22:174–8. 10.1111/j.1365-2303.2010.00766.x
- Varadarajulu S, Bang JY, Holt BA, et al. . The 25-gauge EUS-FNA needle: good for on-site but poor for off-site evaluation? Results of a randomized trial. Gastrointest Endosc 2014;80:1056–63. 10.1016/j.gie.2014.05.304
Source: PubMed